Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
NCT05144464Phase 4Unknown
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Sep 2021
- Primary completion
- Nov 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quadrivalent influenza vaccine in influenza, sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoints: Seroconversion Rate and Adverse Reactions. Status: unknown.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05144464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05144464.